[Psychodynamics of aggression in neurotic structures]. / Ku psychodynamike agresie u neurotických struktúr.

The authors describe the psychodynamics of aggressive attitude and behaviour in schizoid, depressive, obsessive and hysterical neurotic personality structures (personality disorders) as well as in different psychosomatic syndromes. Outline of development of views regarding aggressiveness in deep psychology and important conclusions of ethological research. Implications for therapeutic practice and the solution of relationships between the therapist and patient in the therapeutic team.

[Psychotherapy in psychiatry (and in medicine in general)]. / Psychoterapia v psychiatrii (a medicíne vôbec).

The author subscribes to the view that psychotherapy has an inalienable place in the bio-psycho-social model in psychiatry, and in medicine in general; psychotherapy makes up part of the plurality of therapeutic methods which is adequate to the stratification of being. The plurality of psychotherapeutic methods is, in turn, adequate to the diversity of problems encountered in mental and psychosomatic disease. Emphasis is laid of the psychotherapeutic aspects of psychiatric examination and on the importance of very short interviews in clinical practice. Future developments as regards the integration of psychotherapy into medicine, and professionalism in the field of psychotherapy remain to be open questions.

Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon. Experimental and clinical study.

Chlorpromazine (CHP) in a concentration of 8.3 microgram per ml medium inhibited attachment and multiplication of CEC and of various cell lines. The same CHP concentration applied to grown CEC monolayers inhibited the growth of TBEV but not the growth of HHV 1, while interferon was slightly stimulated. The clinical course of fatal subcutaneous TBEV infection in mice was not affected by daily CHP treatment while brain and serum interferon were stimulated. Antibody formation in TBEV infected or HHV 1 immunized mice was not affected significantly by CHP application. The following data were obtained in a longitudinal study on 28 hospitalized schizophrenic patients: 89 percent of them revealed at least some serological findings which indicate an actual HHV 1 infectious process-elevated NAB titers, high ratio between complement requiring and complement not requiring NAB titers. A low interferon activity was observed in serum and cerebrospinal fluid of 93 percent and 14 percent patients, respectively. No regular correlation between HHV 1-NAB-both complement requiring and complement not requiring-and of interferon on one side and between hospitalization. CHP treatment and electroconvulsive therapy on the other side has been observed.